THOMSON SCIENTIFIC LAUNCHES LIQUENT INSIGHT PUBLISHER TO ENABLE EFFICIENT SUBMISSION PUBLISHING
Philadelphia, PA, USA - London, UK - January 20, 2006 — Pharmaceutical companies have a new tool to enhance their efficiency, reduce time to market, and ensure they are compliant with the latest regulatory guidelines and specifications. Liquent InSight® Publisher — the latest addition to the Liquent InSight suite — simplifies, automates, and accelerates the entire regulatory publishing process. It enables life sciences companies to quickly and easily create, review, and amend regulatory dossiers and submit them for market approval.
Since the early 1990s, there has been an increasing focus on moving many of the regulatory review aspects of new drug approvals to an electronic medium. The Electronic Common Technical Document (eCTD) is a standard that helps regulatory authorities to evaluate drug submissions quickly and accurately, and to approve pharmaceutical products that could save lives. Today, many companies are beginning to consider the business process implications of implementing the eCTD. Over three-quarters of the companies recently surveyed in the 2005 Liquent Regulatory Trends Survey indicated that they intend to implement the use of the eCTD format in the next two years.
InSight Publisher enables users to quickly create all the necessary components for a compliant eCTD submission and easily manage subsequent amendments, supplements and variations to submissions. It makes it simple to create multiple submissions in multiple regions using comprehensive, built-in templates, and to automatically transform documents in multiple file formats into enhanced PDFs with bookmarks and hyperlinks.
Jim Nichols, Liquent's Vice President of Product Strategy and Marketing said, “Life Sciences organizations are looking for integrated solutions that can effectively manage product registrations, dossiers and documents over time. The Liquent InSight suite helps these organizations to turn new regulations into an opportunity and position themselves for successful product development, launch and maintenance.”
As part of the launch program for InSight Publisher, current CoreDossier® and EZsubs® clients have been offered InSight Publisher as part of their maintenance program. Several companies have taken up the offer to date.
A six city road show to support the launch of InSight Publisher commences in Princeton, USA on Feb 14 before moving to Chicago, San Francisco, London, Amsterdam and Basel over a two week period. The solution will also be showcased at the DIA Electronic Document Management Conference, February 7 to 10 in Philadelphia, USA.
About Liquent regulatory solutions
Liquent regulatory solutions provides software, information products, and related services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.
As a result, 48 of the top 50 global life sciences companies rely on Liquent regulatory solutions to stay current with the latest intelligence and to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients and physicians' timely access to new drugs. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent world-class products and expert services. For more information please visit, www.liquent.com.
Thomson Reuters (www.thomsonreuters.com), with 2005 revenues of approximately $8.5 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 40,500 employees and provides services in approximately 130 countries. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).
Scientific is a business of Thomson Reuters. Its information solutions assist professionals at every stage of research and development—from discovery to analysis to product development and distribution. Thomson scientific information solutions can be found at www.scientific.thomson.com.